FDA Warning Letter — Genzyme Ireland Limited
The FDA took a Warning Letter action against Genzyme Ireland Limited on June 22, 2026 (Waterford, Ireland). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Genzyme Ireland Limited
- Date
- June 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Center
- CBER
- Location
- Waterford (Ireland)